Tower Research Capital LLC (TRC) - AIM IMMUNOTECH INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of AIM IMMUNOTECH INC
ValueSharesWeighting
Q3 2023$420
-86.9%
925
-80.7%
0.00%
Q2 2023$3,206
+320500.0%
4,785
+157.4%
0.00%
Q1 2023$11,859
+824.9%
0.00%
Q4 2022$02010.0%0.00%
Q3 2022$02010.0%0.00%
Q2 2022$02010.0%0.00%
Q1 2022$0
-100.0%
201
-95.9%
0.00%
Q4 2021$4,000
-81.0%
4,872
-49.9%
0.00%
-100.0%
Q2 2021$21,000
-4.5%
9,733
-22.2%
0.00%0.0%
Q4 2020$22,00012,5130.00%
Other shareholders
AIM IMMUNOTECH INC shareholders Q4 2023
NameSharesValueWeighting ↓
XTX MARKETS LLC 11,873$26,0000.12%
GSA CAPITAL PARTNERS LLP 95,754$206,0000.03%
Arkadios Wealth Advisors 20,000$45,400,0000.02%
Bayesian Capital Management, LP 42,200$91,0000.02%
SeaCrest Wealth Management, LLC 50,515$109,0000.02%
Virtu Financial LLC 29,604$64,0000.01%
Traynor Capital Management, Inc. 14,777$31,0000.01%
WEDBUSH SECURITIES INC 13,295$29,0000.00%
Verition Fund Management LLC 40,000$86,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 11,600$25,0000.00%
View complete list of AIM IMMUNOTECH INC shareholders